IDXX earnings date and last-quarter result: last quarter beat, P/E 39.87. Updated 2026-07-23.
IDEXX Laboratories (IDXX) Research Hub
IDEXX Laboratories (IDXX) trades on NASDAQ, US in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-10-26, shares last closed at 570.21 USD (+1.75%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 39.87, market cap 43.29B. This hub links to the full technical, earnings and options research available for IDXX.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Diagnostics & Research) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 570.21 USD (+1.75%) |
| 52-week range | 500.61 USD – 624.15 USD |
| Trend regime | Range |
| 14-day RSI | 74.8 (Overbought) |
| Trailing P/E | 39.87 |
| Market cap | 43.29B |
| Dividend yield | 0.00% |
Available research for IDXX
Covered Call on IDXX: how it works, illustrative setup around the real 570.21 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on IDXX: how it works, illustrative setup around the real 570.21 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on IDXX: how it works, illustrative setup around the real 570.21 USD price, max profit/loss, breakeven and when to use it. Educational.
IDXX technical analysis: range, last 570.21 USD, RSI 74.8, 52w range 500.61 USD–624.15 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is IDXX in?
IDEXX Laboratories (IDXX) is classified under Healthcare (Medical - Diagnostics & Research), listed on NASDAQ, US.
Is IDXX in an uptrend or downtrend?
As of 2026-10-26, IDXX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is IDXX's trailing P/E ratio?
IDXX's trailing P/E is 39.87, with a market cap of 43.29B. See the earnings research page for full valuation detail.